Formulation of artemisinin tablets

International Journal of Pharmaceutics

Volumn 146, Issue 2, 1997, Pages 271-274

  Ngo, Thu Hoa ^a   Vertommen, Jan ^a   Kinget, Renaat ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Artemisinin; Factorial design; Formulation; Tablets

Indexed keywords

ARTEMISININ; DOCUSATE SODIUM; GELATIN; GLYCEROL; LACTOSE; MAGNESIUM STEARATE; STARCH; STARCH GLYCOLATE SODIUM;

ARTICLE; DISSOLUTION; DRUG FORMULATION; DRUG SOLUBILITY; METHODOLOGY; PRIORITY JOURNAL; TABLET DISINTEGRATION;

EID: 0343683301     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04795-3     Document Type: Article

References (15)

1. Armstrong, N.A. and James K.C., Understanding experimental design and interpretation in pharmaceutics, 1st edn., Ellis Horwood, London, 1990, pp. 7-45.
2. Doornbos, D.A. and De Haan, P., Optimization techniques in formulation and processing. In Swarbrick, J. and Boylan, J.C. (Eds), Encyclopedia of Pharmaceutical Technology, Vol. XI, Marcel Dekker, New York, 1995, pp. 75-160.
3. Finholt, P., Influence of formulation on dissolution rate. In Leeson, L.J., Cartensen, J.T. (Eds), Dissolution technology, 1st edn., Academy of Pharmaceutical Science, Washington, 1974. pp. 106-146.
4. Hien, T.T. and White, N.J., Qinghaosu. Lancet, 341 (1993) 603-608.
5. Klayman, D.L., Qinghaosu (artemisinin): an antimalarial drug from China. Sciences. 228 (1985) 1049-1055.
6. Li Guo Qiao, Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J. Trad. Chinese Med., 2 (1982) 125-130.
7. Luo, X.D. and Shen, C.C., The Chemistry, Pharmacology and Clinical Application of Qinghaosu (Artemisinin) and its derivatives. Med. Res. Rev., 7 (1987) 29-52.
8. Ngo, T.H., Michoel, A. and Kinget, R., Dissolution testing of artemisinin solid oral dosage forms. Int. J. Pharm., 138 (1996) 185-190.
9. Ngo, T.H. and Kinget, R., Design and evaluation of two phase partition-dissolution method and its use in evaluating artemisinin tablets. J. Pharm. Sci., 85 (1996) 1060-1063.
10. Thai Thong, S. and Beale, G.H., Susceptibility of Thai isolates of Plasmodium falciparum to artemisinin (qinghaosu) and artemether. Bull, Who, 63 (1985) 617-619.
11. Tiulaer, H.A.C., Zuidema, J. and Lugt, C.B., Formulation and pharmacokinetic of artemisinin and its derivatives. Int. J. Pharm, 69 (1991) 83-92.
12. Trigg, P.I., Qinghaosu (artemisinin) as an antimalarial drug. In Wagner, H., Hikino Hirishi, Farnsworth, N.R. (Eds), Economic and Medicinal Plant Research, 1st edn., Vol. 3, Academic Press, London, 1989, pp. 20-55.
13. Wehrle, P., Nobelis, P. and Stamm, A., Principales méthodes d'optimisation employées en génie pharmaceutique, S.T.P. Pharma. 5 (1989) 481-489.
14. WHO, The development of Qinqhaosu and its derivatives as antimalarial drugs, Fourth Meeting of the Scientific Working Group on Chemotherapy of Maleria, Beijing, People's Republic of China.
15. Woerdenbag, H.J., Pras, N., Van Uden, W., Wallaart, T.E., Beekman, A.C., Lugt, C.B., Progress in the research of artemisinin related antimalarials: an update. Pharm. World Sci., 16 (1994) 169-180.